Allworth Financial’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66K | Sell |
38
-14
| -27% | -$611 | ﹤0.01% | 3780 |
|
|
2025
Q1 | $1.75K | Buy |
52
+23
| +79% | +$772 | ﹤0.01% | 3255 |
|
|
2024
Q4 | $1.28K | Hold |
29
| – | – | ﹤0.01% | 3316 |
|
|
2024
Q3 | $1.37K | Hold |
29
| – | – | ﹤0.01% | 3106 |
|
|
2024
Q2 | $1.25K | Hold |
29
| – | – | ﹤0.01% | 3093 |
|
|
2024
Q1 | $1.17K | Hold |
29
| – | – | ﹤0.01% | 3032 |
|
|
2023
Q4 | $739 | Buy |
+29
| New | +$739 | ﹤0.01% | 3043 |
|
|
2023
Q3 | – | Sell |
-113
| Closed | -$2.6K | – | 3494 |
|
|
2023
Q2 | $2.6K | Sell |
113
-6
| -5% | -$138 | ﹤0.01% | 2377 |
|
|
2023
Q1 | $3.53K | Buy |
119
+100
| +526% | +$2.96K | ﹤0.01% | 2178 |
|
|
2022
Q4 | $474 | Sell |
19
-3
| -14% | -$75 | ﹤0.01% | 2643 |
|
|
2022
Q3 | $0 | Buy |
+22
| New | – | ﹤0.01% | 2892 |
|